Manufacturing
EMA issues Q&A guideline on additive manufacturing
EMA has published a new Q&A guideline focused on GMP and quality aspects related to 3D printing in pharmaceutical manufacturing. The document applies to human and veterinary medicines as well as investigational products
IFPMA’s position on AI in pharmaceutical manufacturing
Artificial Intelligence (AI) and Machine Learning (ML) are playing an increasingly central role in pharmaceutical manufacturing and control. A position paper published by IFPMA in March 2026 outlines both the opportunities and the challenges associated with their adoption across the sector
R&D
Progress in conducting clinical trials in the EU
The first report on the state of clinical trials in Europe, published jointly by the European Commission, HMA, and EMA, provides an overview of active clinical trials in the first quarter of 2026 and compares current performance with the objectives established under the Accelerating Clinical Trials in the EU (ACT EU) initiative
The role of quantum mechanics in drug discovery
Quantum mechanics allows us to obtain very accurate results in the study of molecules. Over the years, numerous computational methods have been developed that are capable of studying the system under examination with different approaches, always rigorously based on quantum theories
















